Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Mirjam Fässler(Kantonsspital St. Gallen), Lukas Flatz(Leman University)
Cited by 85
Related Papers
Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036
|European Journal of Cancer|2021|150
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
|Nature Communications|2024|19